Back to News
Market Impact: 0.15
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cellectis S.A.
Source: globenewswire.com
Legal & LitigationHealthcare & Biotech
Pomerantz LLP said it is investigating claims on behalf of investors in Cellectis S.A. (NASDAQ: CLLS) and invited investors to contact the firm. The notice provides no details about the claims or any findings.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly negative
Sentiment Score
-0.15
Ticker Sentiment
CLLS-0.55
More News
- Australia top court rules against coal mine expansion, citing climate harm
- CNN, CBS News now under one roof as Paramount-Warner Bros merger closes
- Why is Telix Pharmaceuticals stock rallying today?
- Sigma Lithium stock rises after court upholds mining licenses
- Corteva just underwent a big spinoff. JPMorgan says the agriculture stock is now poised for big gains
- Skydance Shares Slide After Merger With Warner Bros. Discovery
From AllMind Research
- Anthropic IPO Preview: Valuation, Timing, and What to Watch
- Shein After the IPO: Venue, Valuation, and What Must Be Proved
- What AI Research Tools Should a Small Hedge Fund Buy First?
- Weekly Update: AI-Powered Report Editing, Investor Relations, and Enhanced Search
- Automating Financial Model Updates: A Source-Controlled Workflow